Biosynthesis of uridine diphosphate N-Acetylglucosamine: An underexploited pathway in the search for novel antibiotics?

IUBMB Life. 2022 Dec;74(12):1232-1252. doi: 10.1002/iub.2664. Epub 2022 Jul 26.

Abstract

Although the prevalence of antibiotic resistance is increasing at an alarming rate, there are a dwindling number of effective antibiotics available. Thus, the development of novel antibacterial agents should be of utmost importance. Peptidoglycan biosynthesis has been and is still an attractive source for antibiotic targets; however, there are several components that remain underexploited. In this review, we examine the enzymes involved in the biosynthesis of one such component, UDP-N-acetylglucosamine, an essential building block and precursor of bacterial peptidoglycan. Furthermore, given the presence of a similar biosynthesis pathway in eukaryotes, we discuss the current knowledge on the differences and similarities between the bacterial and eukaryotic enzymes. Finally, this review also summarises the recent advances made in the development of inhibitors targeting the bacterial enzymes.

Keywords: UDP-N-acetylglucosamine biosynthesis; antibiotic resistance; bifunctional GlmU; glucosamine-6-phosphate synthase; peptidoglycan biosynthesis; phosphoglucosamine mutase.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Peptidoglycan
  • Uridine Diphosphate N-Acetylglucosamine* / metabolism

Substances

  • Uridine Diphosphate N-Acetylglucosamine
  • Anti-Bacterial Agents
  • Peptidoglycan